[HTML][HTML] The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin-Neto, A Rassi Jr, A Avezum Jr… - Memórias do Instituto …, 2009 - SciELO Brasil
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

[PDF][PDF] The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin-Neto, AR Jr, AA Jr, AC Mattos, A Rassi - core.ac.uk
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin-Neto, A Rassi Jr… - Memorias do …, 2009 - pubmed.ncbi.nlm.nih.gov
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

[HTML][HTML] The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin-Neto, A Rassi Jr, A Avezum Jr… - Memórias do Instituto …, 2009 - SciELO Brasil
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

[PDF][PDF] The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin Neto, A Rassi Junior… - Memórias do Instituto …, 2009 - repositorio.usp.br
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease.

JA Marin Neto, AJ Rassi, AJ Avezum, AC Mattos… - 2009 - cabidigitallibrary.org
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin-Neto, A Rassi Jr, A Avezum Jr, AC Mattos… - sidalc.net
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

[PDF][PDF] The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin-Neto, AR Jr, AA Jr, AC Mattos, A Rassi - researchgate.net
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

[PDF][PDF] The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin-Neto, AR Jr, AA Jr, AC Mattos, A Rassi - Citeseer
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …

[PDF][PDF] The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

JA Marin-Neto, AR Jr, AA Jr, AC Mattos, A Rassi - pdfs.semanticscholar.org
Among the pathophysiological derangements operating in the chronic phase of Chagas
disease, parasite persistence is likely to constitute the main mechanism of myocardial injury …